2018
DOI: 10.2340/20030711-1000012
|View full text |Cite
|
Sign up to set email alerts
|

CD34+ stem cell treatment for knee osteoarthritis: a treatment and rehabilitation algorithm

Abstract: Osteoarthritis of the knee joint is a chronic disease that mainly affects people over 50 years of age. The main symptoms include pain and limitation of range of motion of the joint, which prevent patients from participating in physical activity. Stem cell therapy has been developed in orthopaedics in recent years for the treatment of gonarthrosis. Rehabilitation is necessary after stem cell transplantation in patients with gonarthrosis in order to restore the proper range of joint mobility, for anti-oedematous… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 35 publications
0
4
0
Order By: Relevance
“…To further enhance the therapeutic potential of HSCT, CD34 + stem cells were proposed to be used in combination with the rehabilitation algorithm, which included three stages: preoperative, hospitalization and outpatient periods. 68 Currently, a large wave of studies has been directed to MSC-based therapy for the treatment of OA due to their immunoregulatory functions and anti-inflammatory characteristics. MSCs have been used as the main cell source in several multiple and small-scale trials, proving their safety profile and potential effectiveness in alleviating pain, reducing cartilage degeneration, and enhancing the regeneration of cartilage structure and morphology in some cases.…”
Section: Stem Cell-based Therapy: An Overview Of Current Clinical App...mentioning
confidence: 99%
“…To further enhance the therapeutic potential of HSCT, CD34 + stem cells were proposed to be used in combination with the rehabilitation algorithm, which included three stages: preoperative, hospitalization and outpatient periods. 68 Currently, a large wave of studies has been directed to MSC-based therapy for the treatment of OA due to their immunoregulatory functions and anti-inflammatory characteristics. MSCs have been used as the main cell source in several multiple and small-scale trials, proving their safety profile and potential effectiveness in alleviating pain, reducing cartilage degeneration, and enhancing the regeneration of cartilage structure and morphology in some cases.…”
Section: Stem Cell-based Therapy: An Overview Of Current Clinical App...mentioning
confidence: 99%
“…Patients are increasingly seeking new and innovative treat- Adres do korespondencji / Corresponding author ments to preserve their joint and avoid endoprosthesis. One such solution is treatment with CD34+ stem cells [10].…”
Section: Discussionmentioning
confidence: 99%
“…still on the operating table. A specialist team of qualified physiotherapists, together with an original method of a jointly developed algorithm of posttreatment rehabilitation, mobilized to systematic work twice a day, 7 days a week [9,10]. During the first four days after surgery, the patient was strictly forbidden to put any weight on the operated limb, positioning therapy was applied, and light passive exercises were carried out up to the pain limit, together with gentle traction of the hip joint.…”
Section: A Case Reportmentioning
confidence: 99%
“…However, this logic has recently been contested [10,11]. While the role of other cell types unique to the bone marrow including CD34 + hematopoietic progenitor/ precursor [12] cells and platelets [13] has been proposed as contributors to the therapeutic value of BMC, the value of MSCs in the BMC remains a pinnacle.…”
Section: Introductionmentioning
confidence: 99%